These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9279893)
1. Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Sakane T; Pardridge WM Pharm Res; 1997 Aug; 14(8):1085-91. PubMed ID: 9279893 [TBL] [Abstract][Full Text] [Related]
2. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pardridge WM; Wu D; Sakane T Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954 [TBL] [Abstract][Full Text] [Related]
3. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Zhang Y; Pardridge WM Brain Res; 2001 Jan; 889(1-2):49-56. PubMed ID: 11166685 [TBL] [Abstract][Full Text] [Related]
4. The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. Jiang X; Tian F; Mearow K; Okagaki P; Lipsky RH; Marini AM J Neurochem; 2005 Aug; 94(3):713-22. PubMed ID: 16000165 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotection with noninvasive neurotrophin delivery to the brain. Wu D; Pardridge WM Proc Natl Acad Sci U S A; 1999 Jan; 96(1):254-9. PubMed ID: 9874805 [TBL] [Abstract][Full Text] [Related]
6. Co-infusion with a TrkB-Fc receptor body carrier enhances BDNF distribution in the adult rat brain. Croll SD; Chesnutt CR; Rudge JS; Acheson A; Ryan TE; Siuciak JA; DiStefano PS; Wiegand SJ; Lindsay RM Exp Neurol; 1998 Jul; 152(1):20-33. PubMed ID: 9682009 [TBL] [Abstract][Full Text] [Related]
7. PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution. Soderquist RG; Milligan ED; Sloane EM; Harrison JA; Douvas KK; Potter JM; Hughes TS; Chavez RA; Johnson K; Watkins LR; Mahoney MJ J Biomed Mater Res A; 2009 Dec; 91(3):719-29. PubMed ID: 19048635 [TBL] [Abstract][Full Text] [Related]
8. Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury. Ankeny DP; McTigue DM; Guan Z; Yan Q; Kinstler O; Stokes BT; Jakeman LB Exp Neurol; 2001 Jul; 170(1):85-100. PubMed ID: 11421586 [TBL] [Abstract][Full Text] [Related]
9. Conformational stability of lyophilized PEGylated proteins in a phase-separating system. Heller MC; Carpenter JF; Randolph TW J Pharm Sci; 1999 Jan; 88(1):58-64. PubMed ID: 9874703 [TBL] [Abstract][Full Text] [Related]
11. Comparison of neurotrophin regulation of human and rat neuropeptide Y (NPY) neurons: induction of NPY production in aggregate cultures derived from rat but not from human fetal brains. Barnea A; Aguila-Mansilla N; Chute HT; Welcher AA Brain Res; 1996 Sep; 732(1-2):52-60. PubMed ID: 8891268 [TBL] [Abstract][Full Text] [Related]
12. Effect of controlled release of brain-derived neurotrophic factor and neurotrophin-3 from collagen gel on neural stem cells. Huang F; Wu Y; Wang H; Chang J; Ma G; Yin Z Neuroreport; 2016 Jan; 27(2):116-23. PubMed ID: 26656937 [TBL] [Abstract][Full Text] [Related]
13. TrkB mutant lacking the amino-terminal half of the extracellular portion acts as a functional brain-derived neurotrophic factor receptor. Kojima S; Nakayama T; Kuwajima G; Suzuki H; Sakata T Biochim Biophys Acta; 1999 Aug; 1420(1-2):104-10. PubMed ID: 10446295 [TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor modulates GAP-43 but not T alpha1 expression in injured retinal ganglion cells of adult rats. Fournier AE; Beer J; Arregui CO; Essagian C; Aguayo AJ; McKerracher L J Neurosci Res; 1997 Mar; 47(6):561-72. PubMed ID: 9089204 [TBL] [Abstract][Full Text] [Related]
15. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Tsuchida A; Nakagawa T; Itakura Y; Ichihara J; Ogawa W; Kasuga M; Taiji M; Noguchi H Diabetologia; 2001 May; 44(5):555-66. PubMed ID: 11380073 [TBL] [Abstract][Full Text] [Related]
16. Distinct populations of hypothalamic dopaminergic neurons exhibit differential responses to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3). Loudes C; Petit F; Kordon C; Faivre-Bauman A Eur J Neurosci; 1999 Feb; 11(2):617-24. PubMed ID: 10051762 [TBL] [Abstract][Full Text] [Related]
17. Purification and characterisation of a brain-derived neurotrophic factor/neurotrophin-3 (BDNF/NT-3) heterodimer. Jungbluth S; Bailey K; Barde YA Eur J Biochem; 1994 Apr; 221(2):677-85. PubMed ID: 8174548 [TBL] [Abstract][Full Text] [Related]
18. Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro. Schmidt N; Schulze J; Warwas DP; Ehlert N; Lenarz T; Warnecke A; Behrens P PLoS One; 2018; 13(3):e0194778. PubMed ID: 29584754 [TBL] [Abstract][Full Text] [Related]
19. Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures. Marmigère F; Choby C; Rage F; Richard S; Tapia-Arancibia L Neuroendocrinology; 2001 Jul; 74(1):43-54. PubMed ID: 11435757 [TBL] [Abstract][Full Text] [Related]
20. Structural determinants of Trk receptor specificities using BDNF-based neurotrophin chimeras. Lai KO; Glass DJ; Geis D; Yancopoulos GD; Ip NY J Neurosci Res; 1996 Dec; 46(5):618-29. PubMed ID: 8951673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]